M&A Deal Summary

Voiant Acquires DARC

On September 3, 2021, Voiant acquired life science company DARC

Acquisition Highlights
  • This is Voiant’s 1st transaction in the Life Science sector.
  • This is Voiant’s 1st transaction in the United States.
  • This is Voiant’s 1st transaction in New York.

M&A Deal Summary
Date 2021-09-03
Target DARC
Sector Life Science
Buyer(s) Voiant
Deal Type Add-on Acquisition

Target

DARC

Great Neck, New York, United States
DARC is an ophthalmology imaging core lab. DARC provides retinal imaging evaluation services for more than 100 studies involving sites in 70 countries. DARC was founded in 1998 and is based in Great Neck, New York.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Voiant

Waltham, Massachusetts, United States
Category Company
Founded 1992
Sector Life Science
DESCRIPTION

Voiant is a provider of imaging core laboratory services and other blinded centralized review services for pharmaceutical and medical device clinical trials. Voiant was founded in 1992 and is based in Waltham, Massachusetts.

DEAL STATS #
Overall 1 of 2
Sector (Life Science) 1 of 2
Type (Add-on Acquisition) 1 of 1
State (New York) 1 of 1
Country (United States) 1 of 2
Year (2021) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-09-13 MedQIA

Los Angeles, California, United States

MedQIA is a global, full service, contract research organization specializing in Quantitative Image Analysis for clinical trials. MedQIA provides a full range of CRO services and handles all aspects of your clinical trial from planning to completion. The company specializes in delivering cutting-edge quantitative imaging biomarkers in Phase I through IV studies for drugs and in medical devices. MedQIA is based in Los Angeles, California.

Buy -
Mergr

Product

Company

Legal